OpportunityTitle: Substance Use and Abuse among U.S. Military Personnel, Veterans and their Families (R01)
AdditionalInformationOnEligibility: Other Eligible Applicants include the following:  Alaska Native and Native Hawaiian Serving Institutions; Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession.
Description: Purpose. This Funding Opportunity Announcement (FOA) is issued by NIDA, NIAAA, NCI, and the Department of Veterans Affairs (VA) to enhance and accelerate research on the epidemiology/etiology, identification, and prevention and treatment of alcohol, tobacco, and other drug use and abuse (including illicit and prescription drugs) and associated mental health problems among active-duty or recently separated (e.g., Iraq and Afghanistan) military troops and their families. VA has specific interest in supporting research directed towards advancing prevention and treatment of mental health and comorbid substance use/abuse problems in veterans of Iraq and Afghanistan deployments (including National Guard and Reservists) and their families. Mechanism of Support. This FOA will utilize the R01 grant mechanism and runs in parallel with a FOA of identical scientific scope, RFA-DA-10-002 that solicits applications under the R21 mechanism. Funds Available and Anticipated Number of Awards. For this FOA combined with the parallel R21 FOA (RFA-DA-10-002), the participating organizations intend to commit approximately $7.0 million (total costs) in Fiscal Year 2010 with which it is expected that 11 to 21 new grants will be funded across the two FOAs. Specifically, in Fiscal Year 2010, NIDA intends to commit approximately $2.0 million (total costs),NIAAA intends to commit approximately $2.0 million (total costs), and NCI intends to commit approximately $1.0 million (total costs). In addition, the VA Clinical Science Research and Development Service (CSRD) estimates committing up to $2.0 million (total costs) for this FOA (VA encourages applications to the R21 FOA but will not participate in funding the R21 proposals).
GrantorContactEmailDescription: If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster
GrantorContactText: NIH OER Webmaster&lt;br/&gt;FBOWebmaster@OD.NIH.GOV&lt;br/&gt;